Top 300 Drug Cards 2016/2017

by Usatine Media LLC

free


not available



The best and easiest way to learn essential information about the top 300 drugsThis edition is enhanced by 11 new cards, key adult and pediatric immunization vaccines, and recently approved hepatitis C vaccines.
Every card includes:• Generic and common name• Class• Dosage Forms• Approved Dose and Indications• Off-Label Use• Contraindications• Adverse Reactions• Drug Interactions• Monitoring Parameters• Medication Safety Issues and Black Box Warnings• Clinical pearls that help guide patient care• Strong focus on patient safety
Each card also features a photograph as well as important drug information. You can also search the entire text with our lightning fast search tool. The search tool shows you suggested words as you type so it is quick and helps with spelling issues. You can also add notes to each drug card, as well as bookmark drug cards as Know and Don't Know to help with studying. You also have the ability to change the text size for easier reading. No internet connection needed to view the full app. It is all ready for super quick image and information retrieval. This app is optimized for whatever size device you are using, either phone or tablet.
This interactive app is based on the full content of McGraw-Hill's 2016/2017 Top 300 Pharmacy Drug Cards by McGraw-Hill.
Editors: Jill M. Kolesar, PharmD, BCPS, FCCP Professor, UW-Madison School of Pharmacy Director, Analytical Instrumentation Laboratory for Phamacokinetics, Pharmacodynamics and Phamacogenetics (3P) University of Wisconsin Carbone Comprehensive Cancer Center Madison, Wisconsin
Lee C. Vermeulen, RPh, MS, FCCP, FFIP Clinical Professor, UW-Madison School of Pharmacy Director, Center for Clinical Knowledge Management, UW HealthMadison, Wisconsin
Disclaimer: This app is intended for the education of healthcare professionals and not as a diagnostic and treatment reference for the general population.
Developed by Usatine Media, LLC Richard P. Usatine, MD, Co-President, Professor of Family & Community Medicine, Professor of Dermatology and Cutaneous Surgery, University of Texas Health Science Center San Antonio Peter Erickson, Co-President, Lead Software Developer